News
LexCase regularly publishes articles on the most relevant news, be it regulations, case law or various opinions.

LexCase’s Health Law and Life Sciences department is once again ranked TIER 2 in the Legal 500 EMEA 2025 ranking, in the Healthcare and Life Sciences category.
01/04/2025
![[DISTINCTION] Diane BANDON TOURET honored as “Stand-out Lawyer” by Thomson Reuters](https://lexcase.com/wp-content/uploads/2025/03/Distinctions-1-365x120.png)
[DISTINCTION] Diane BANDON TOURET honored as “Stand-out Lawyer” by Thomson Reuters
25/03/2025
![[Welcome] Valentin RENOUX joins LexCase as Partner](https://lexcase.com/wp-content/uploads/2025/01/Valentin-RENOUX5-365x120.jpg)
[Welcome] Valentin RENOUX joins LexCase as Partner
13/01/2025
![[LIFE SCIENCE]The new Product Liability Directive has been adopted and published in the Official Journal of the European Union: focus on the novelties to be transposed by December 2026](https://lexcase.com/wp-content/uploads/2023/04/Flash-actu-Industrie-de-Sante-26-09-22--365x120.jpg)
[LIFE SCIENCE]The new Product Liability Directive has been adopted and published in the Official Journal of the European Union: focus on the novelties to be transposed by December 2026
22/11/2024

New European regulations on substances of human origin (SoHO)
24/09/2024
![[DISTINCTION] Best Lawyers 2025 LexCase distinguished in 7 catégories !](https://lexcase.com/wp-content/uploads/2024/06/Actu-palmares-Best-Lawyers-2025-365x120.jpg)
[DISTINCTION] Best Lawyers 2025 LexCase distinguished in 7 catégories !
20/06/2024

New distinction for the Healthcare Industries Department, in the Who’s Who Legal ranking 2024
23/04/2024

Distinction of the LifeSciences Department in TIER 2 of the Legal 500 EMEA 2024
27/03/2024
Distinction of the LifeSciences Department in TIER 2 of the Legal 500 EMEA

The LifeSciences team distinguished, once again, by The Legal 500 (Legalease) en TIER 2 en Industry Focus: Healthcare and LifeSciences.
Congratulations to the team and a huge thank you to our clients for their testimonials.
“The quality of the legal analysis, the availability of the team, the speed of execution, the pragmatic nature of the analyses, the command of English, the teamwork stand out.”
“Excellent knowledge of pharmaceutical regulations and regulatory subtleties. Excellent ability to advise by weighing the benefits and risks and being objective. Strength of proposal.”